Citadel Advisors’s Avidity Biosciences RNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $617K | Buy |
21,722
+5,540
| +34% | +$157K | ﹤0.01% | 3826 |
|
|
2025
Q1 | $478K | Sell |
16,182
-395,493
| -96% | -$11.7M | ﹤0.01% | 4024 |
|
|
2024
Q4 | $12M | Buy |
+411,675
| New | +$12M | ﹤0.01% | 1213 |
|
|
2024
Q3 | – | Sell |
-160,777
| Closed | -$6.57M | – | 6557 |
|
|
2024
Q2 | $6.57M | Buy |
160,777
+57,644
| +56% | +$2.35M | ﹤0.01% | 1480 |
|
|
2024
Q1 | $2.63M | Sell |
103,133
-390,529
| -79% | -$9.97M | ﹤0.01% | 2258 |
|
|
2023
Q4 | $4.47M | Buy |
493,662
+263,314
| +114% | +$2.38M | ﹤0.01% | 1728 |
|
|
2023
Q3 | $1.47M | Sell |
230,348
-122,899
| -35% | -$784K | ﹤0.01% | 2679 |
|
|
2023
Q2 | $3.92M | Buy |
353,247
+248,225
| +236% | +$2.75M | ﹤0.01% | 1884 |
|
|
2023
Q1 | $1.61M | Buy |
105,022
+97,398
| +1,278% | +$1.5M | ﹤0.01% | 2712 |
|
|
2022
Q4 | $169K | Sell |
7,624
-48,777
| -86% | -$1.08M | ﹤0.01% | 4783 |
|
|
2022
Q3 | $921K | Buy |
56,401
+17,338
| +44% | +$283K | ﹤0.01% | 3497 |
|
|
2022
Q2 | $568K | Buy |
39,063
+19,965
| +105% | +$290K | ﹤0.01% | 4005 |
|
|
2022
Q1 | $353K | Buy |
+19,098
| New | +$353K | ﹤0.01% | 4790 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 7066 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 6975 |
|
|
2020
Q3 | – | Sell |
-273,220
| Closed | -$7.72M | – | 5164 |
|
|
2020
Q2 | $7.72M | Buy |
+273,220
| New | +$7.72M | ﹤0.01% | 1245 |
|